Our Team

  • We are small and agile, and are working at a “startup” pace.

  • Up and down as founders before, we can see things through your lens

  • We may stay away and bless. However, we are always here, if you need help.

General

Helena Liu

Meditech investor, a Hong Kong financial market license holder and an Asset Management specialist.

Before her Asset Management position in the Hong Kong market (VP of Wisdom Asset Management, VP of Target Capital), Helena also has more than ten years of experience in corporate finance and M&A in the pharmaceutical (AstraZeneca) and medical devices (Philips Investment, China) industries.

Helena holds a Master of Commerce, Finance and Information Systems from the University of Sydney.

PARTNER

Ex-startup founder, ex-strategy consultant and ex-programmer (still a hobby).

Alan co-founded a technology startup (Gentech/Jiangrui Computer Systems) when he was a third-year university student and exited in 4.5 years. After that, Alan worked for 12 years in strategy consulting (Partners in Performance, Accenture Strategy) and corporate strategy (PLUS ES). He was also a strategic partnership executive in AGL New Energy (corporate venture).

Alan holds an MBA from Melbourne Business School, a Master of Computer Science and a Bachelor of Theoretical Physics from Nanjing University.

PARTNER

Alan Cui

Technologist

An international VC veteran with 20 years of experience in early-stage investment

Curt Shi is the founding partner of Imprint Capital Partners, Follow [The] Seed, Welinder & Shi Capital and ProDigital Future Fund, focusing on the complex but massive opportunities in markets such as Australia, Israel, America and China. His recent successful public portfolios include ASX-listed Catapult Sports (ASX:CAT), Jayride (ASX: JAY), Sezzle (ASX:SZL) and Airtasker (ASX:ART). Also, some fast-growing investments such as Cake, SYNG and STEPN.

Curt has also been an active mentor at incubators and accelerators such as Muru-D, Hax/ Orbits, Stone and Chalk, Startupbootcamp, G5 and Chinaccelerator and a frequent speaker for various start-up events.

Curt was the 2016 winner of "the CPA Australia Australia China Alumni Award for Banking and Finance" by the Australia China Alumni Association, a finalist for the “Innovation and Entrepreneurship Alumni Award” of Western Sydney University in 2017, and a 2022 finalist again “Austrade – Australia China Alumni Award for Entrepreneurship & Innovation” by the ACAA (Australia China Alumni Association).

PARTNER

Curt Shi

Startup founder, Corporate Venture Capital Executive

Stu is the CEO and Co-Founder of UPowr, a SaaS cleantech company. Prior to UPowr, Stu was the Head of Strategic Partnerships at AGL Energy New Energy (corporate venture capital and incubator). In New Energy, he was involved in multiple deals with world-leading innovators. As a former rugby league player, Stu Co-Founded The Graduates of League Program covering 16 NRL clubs across Australia and New Zealand.

Stu holds a Master of Finance from the University of New South Wales and a double Bachelor of Law and Commerce from the University of Wollongong.

INVESTMENT COMMITTEE - GENERAL VC

Stu Philpot

Healthcare

Hover Chen

PARTNER, HEAD OF HEALTHCARE FUND

Deep technology investor, Healthcare Industry Expert

Hover is an experienced deep tech investor (Partner of Shanghai Rizhang Investment). Prior to his involvement in the early-stage startup investment, he also worked as an investment manager in Australian hedge funds (Caledonia Investment and Ellerson Capital).

He was the early investor and Chair of the Board of Supervisors* for Zhonghe Bioscience, which later merged and evolved into two listed companies Junshi Bioscience and Mabwell Bioscience.

Hover holds the Master in Corporate Finance from the Chinese Academy of Social Science and the Bachelor of Engineering from the Beijing University of Posts & Telecoms

*Board of Supervisors is a governance structure in China, which is similar to the non-executive directors in Australia

Bruce Gao, PhD

Microbiologist, Genomic Specialist

Dr Bruce Gao is a biotech specialist who specialises in genomics and molecular assay innovation. With an exceptional global educational background and experience as a genomics specialist, Bruce has conducted various projects at the forefront of international research.

Bruce also worked at a world-leading biotechnology company as a genomics SME and was responsible for technical due diligence for its corporate venture capital unit. During his days in Boston, he was exposed to the Venture Studio methodology via his projects in Flagship Pioneering.

Bruce did his PhD at Monash University and post-doctoral training in genomics at Harvard Medical School.

PARTNER

Qiao Qiao, PhD

Seasoned Life Science Commercialisation Professional

Qiao is the founder and principal consultant of Tadpole Bio, where he serves as the Australian director for illustrious Chinese biopharmaceutical companies, including LaNova Medicine, Keythera Pharmaceutical, Trinomab Biotech, Auzone Biological Technology, and Hope Medicine. Qiao also served seven years as a technology transfer professional at UNSW. During his tenure, he landed nearly A$20 million in investments for university spin-offs, facilitated a multitude of academic-industry collaborative research agreements and assumed a voting member in the investment committee of UniSeed.

Qiao obtained his PhD in mesenchymal stem cell area from UNSW and Bachelor from the University of Adelaide. He is also the inaugural chairman of the Knowledge Commercialisation Australasia (KCA) NSW network.

PARTNER

Betty Zhang

Healthcare investor, biomedical researcher, commercialisation specialist

Betty is passionate about early stage healthcare innovation and is experienced in medical research (Walter and Eliza Hall Institute), biotech equity analysis (Churchill Asset Management) and healthcare commercialisation. Betty co-founded the Melbourne Bioinnovation Student Initiative, supporting the creation of student-led health ventures at the University of Melbourne. Before joining Boson Ventures, she was the Early Innovation Lead at the MedTech Actuator, a leading healthcare accelerator in Asia-Pacific.

Betty holds a Bachelor of Science in Biotechnology (Immunology specialisation) from the University of Melbourne.

INVESTMENT ASSOCIATE